Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy.

MLA

McDermott, Martina S. J., et al. “Correction: PP2A Inhibition Overcomes Acquired Resistance to HER2 Targeted Therapy.” Molecular Cancer, vol. 22, no. 1, Oct. 2023, p. 175. EBSCOhost, https://doi.org/10.1186/s12943-023-01890-z.

APA

McDermott, M. S. J., Browne, B. C., Conlon, N. T., O’Brien, N. A., Slamon, D. J., Henry, M., Meleady, P., Clynes, M., Dowling, P., Crown, J., & O’Donovan, N. (2023). Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy. Molecular Cancer, 22(1), 175. https://doi.org/10.1186/s12943-023-01890-z

Chicago

McDermott, Martina S J, Brigid C Browne, Neil T Conlon, Neil A O’Brien, Dennis J Slamon, Michael Henry, Paula Meleady, et al. 2023. “Correction: PP2A Inhibition Overcomes Acquired Resistance to HER2 Targeted Therapy.” Molecular Cancer 22 (1): 175. doi:10.1186/s12943-023-01890-z.